Following encouraging clinical findings , retatrutide, a new peptide therapy for treating non-insulin dependent diabetes , has secured conditional approval from the Drug and Healthcare Agency ( MHRA https://poppygfgb112388.blog-eye.com/41570539/retatrutide-medication-peptide-uk-green-light-and-availability